Trial intelligence / Profile preview

Levothyroxine for difficult weaning from mechanical ventilation in patients with hypothyroidism risk

IRCT20120605009948N7Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Weaning time. Started Mar 2018; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20120605009948N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120605009948N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call